At a glance
ClinicalIndex Comparison RecordN/ACompleted· 106 enrolled
Drug / intervention
CEFALY Active +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device
In Brief
A clinical study evaluating CEFALY Active and CEFALY Placebo for Migraine. Completed, enrolled 106 participants across 3 sites.
Detailed Summary
The main objective of this study is to assess the efficacy of the Cefaly® device as an acute treatment of migraine attack in adult patients. The patients will be applied either an active or placebo external neurostimulation for 1 hour during a migraine attack, and will report the pain on a visual analog scale before and after the treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 2015
Enrollment StartFeb 2016
Primary CompletionMar 2017
TodayJul 2026
First PostedOct 29, 2015
Enrollment StartFeb 1, 2016
Primary CompletionMar 31, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.7 years ago
Interventions
CEFALY Activedevice
Active external trigeminal nerve stimulation
CEFALY Placebodevice
Placebo external trigeminal nerve stimulation